SCHEMBL201672

SCHEMBL201672

CC/C=C/C1CC2C=CC1C2

nearest known ligand 0.36

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 2/20 0.36
GAA P10253 1/20 0.30
ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL201673 1.00 ALDH1A1 (0.36) ALDH1A1KDM4EGAAATM
SCHEMBL27673432 0.87
SCHEMBL7189426 0.85 KDM4E (0.34) ALDH1A1KDM4E
SCHEMBL7189424 0.85 KDM4E (0.34) ALDH1A1KDM4E
SCHEMBL7934709 0.85
SCHEMBL7187727 0.82 ALOX5 (0.35) ALDH1A1KDM4E
SCHEMBL7187732 0.82 ALOX5 (0.35) ALDH1A1KDM4E
SCHEMBL7187244 0.80 ALOX5 (0.40) ALDH1A1KDM4E
SCHEMBL7187245 0.80 ALOX5 (0.40) ALDH1A1KDM4E
SCHEMBL13390932 0.80 GAA (0.35) ALDH1A1KDM4EGAAATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 374 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119948116-A Coating composition with polyolefin network structure SWIMC有限公司 2025-05-06 CN claimed
US-12043573-B2 Adhesion promoters and gel-modifiers for olefin metathesis compositions MATERIA, INC. (US) 2024-07-23 US claimed
EP-3256505-B1 CYCLIC OLEFIN RESIN COMPOSITIONS COMPRISING FUNCTIONAL ELASTOMERS MATERIA INC (US) 2023-11-29 EP claimed
US-20220089481-A1 ADHESION PROMOTERS AND GEL-MODIFIERS FOR OLEFIN METATHESIS COMPOSITIONS MATERIA, INC. (US) 2022-03-24 US claimed
US-20210403654-A1 ADHESION PROMOTER COMPOSITIONS FOR CYCLIC OLEFIN RESIN COMPOSITIONS MATERIA, INC. (US) 2021-12-30 US claimed
US-10907018-B2 Adhesion promoter compositions for cyclic olefin resin compositions MATERIA, INC. (US) 2021-02-02 US claimed
US-10711090-B2 Thermal insulation MATERIA, INC. (US) 2020-07-14 US claimed
EP-3197881-B1 DIAZIRINE COMPOUNDS AS PHOTOCROSSLINKERS AND PHOTOIMAGEABLE COMPOSITIONS COMPRISING THEM PROMERUS LLC (US) 2020-04-29 EP claimed
US-20200115277-A1 ADHESION PROMOTERS AND GEL-MODIFIERS FOR OLEFIN METATHESIS COMPOSITIONS MATERIA, INC. (US) 2020-04-16 US claimed
US-10303060-B2 Diazirine compounds and compositions derived therefrom PROMERUS, LLC (US) 2019-05-28 US claimed
US-9938241-B2 Diazirine compounds and compositions derived therefrom PROMERUS, LLC (US) 2018-04-10 US claimed
US-9803046-B2 In-mold coating of ROMP polymers MATERIA, INC. (US) 2017-10-31 US claimed
US-20160147145-A1 PHOTOIMAGEABLE COMPOSITIONS CONTAINING OXETANE FUNCTIONALITY PROMERUS, LLC 2016-05-26 US claimed
US-20160083352-A1 DIAZIRINE COMPOUNDS AND COMPOSITIONS DERIVED THEREFROM SUMITOMO BAKELITE CO., LTD. (JP) 2016-03-24 US claimed
EP-0298408-B1 METHOD FOR PREPARING NORBORNENE STRUCTURE COMPOUND NIPPON OIL CO. LTD. (JP) 1991-12-18 EP claimed
US-4791170-A BLENDS OF ETHYLENE-ALPHA-OLEFINS AND PHENOLAROMATIC HYDROCARBON COPOLYMERS; TACKINESS NIPPON OIL CO., LTD. (JP) 1988-12-13 US claimed
US-4746712-A GELATION INHIBITION JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1988-05-24 US claimed
US-4695614-A ORGANOALUMINUM COMPOUND, MODIFIED VANADIUM COMPOUND JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1987-09-22 US claimed
EP-0042589-B1 NORBORNENE POLYMERS STABILIZED WITH HINDERED AROMATIC ALCOHOLS The B.F. GOODRICH Company (US) 1985-06-19 EP claimed
US-4324717-A OXIDATION RESISTANCE THE B. F. GOODRICH COMPANY (US) 1982-04-13 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160083352-A1 DIAZIRINE COMPOUNDS AND COMPOSITIONS DERIVED THEREFROM RDX, AOX1, ALDH1A2 ALDH1A1 24/4885KDM4E 2719/4885GAA 2094/4885
US-10303060-B2 Diazirine compounds and compositions derived therefrom ZYX, AOX1, RDX ALDH1A1 145/4885KDM4E 1745/4885GAA 3014/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.